Quantitative transportomics identifies Kif5a as a major regulator of neurodegeneration
Abstract
Many neurons in the adult central nervous system, including retinal ganglion cells (RGCs), degenerate and die after injury. Early axon protein and organelle trafficking failure is a key component in many neurodegenerative disorders yet changes to axoplasmic transport in disease models have not been quantified. We analyzed early changes in the protein 'transportome' from (RGC somas to their axons after optic nerve injury and identified transport failure of an anterograde motor protein Kif5a early in RGC degeneration. We demonstrated that manipulating Kif5a expression affects anterograde mitochondrial trafficking in RGCs and characterized axon transport in Kif5a knockout mice to identify proteins whose axon localization was Kif5a-dependent. Finally, we found that knockout of Kif5a in RGCs resulted in progressive RGC degeneration in the absence of injury. Together with expression data localizing Kif5a to human RGCs, these data identify Kif5a transport failure as a cause of RGC neurodegeneration and point to a mechanism for future therapeutics.
Data availability
All data generated during this study are included in the manuscript and supporting source files in excel format. Source data files have been provided for Figures 1, 4, 5 and Supplementary Figure 2.
-
scRNA-seq of the developing human retinaNCBI Gene Expression Omnibus, GSE138002.
Article and author information
Author details
Funding
National Institutes of Health (EY011261)
- Hollis T Cline
Research to Prevent Blindness
- Jeffrey L Goldberg
National Institutes of Health (U01EY027261)
- John R Yates III III
- Hollis T Cline
- Jeffrey L Goldberg
National Institutes of Health (EY027437)
- Hollis T Cline
National Institutes of Health (P30 EY019005)
- Hollis T Cline
National Institutes of Health (R01MH103134)
- Hollis T Cline
National Institutes of Health (P41 GM103533)
- John R Yates III III
Hahn Family Foundation
- Hollis T Cline
National Institutes of Health (R01MH067880)
- John R Yates III III
National Institutes of Health (P30 EY026877)
- Jeffrey L Goldberg
Glaucoma Research Foundation
- Jeffrey L Goldberg
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Ethics
Animal experimentation: All animal experiments conformed to the ARVO statement for the Use of Animals in Ophthalmic and Vision Research and were reviewed and approved by the Institutional Animal Care and Use Committee (IACUC) and the Institutional Biosafety Committee of University of California, San Diego, Scripps Research, and Stanford University.
Copyright
© 2022, Shah et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 2,138
- views
-
- 327
- downloads
-
- 26
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Citations by DOI
-
- 26
- citations for umbrella DOI https://doi.org/10.7554/eLife.68148